Kaempferol

Kaempferol

SCHEMBL29378805

O=c1c(O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 9/20 1.00
KMT2A Q03164 9/20 1.00
CYP1A2 P05177 8/20 1.00
CYP3A4 P08684 8/20 1.00
ABCB1 P08183 7/20 1.00
CYP2C9 P11712 7/20 1.00
CYP1A1 P04798 7/20 1.00
CYP1B1 Q16678 7/20 1.00
KDM4E B2RXH2 7/20 1.00
FTO Q9C0B1 6/20 1.00
XDH P47989 6/20 1.00
MAPT P10636 6/20 1.00
HSD17B10 Q99714 6/20 1.00
CYP2D6 P10635 6/20 1.00
ALOX15 P16050 5/20 1.00
CYP2C19 P33261 5/20 1.00
APP P05067 5/20 1.00
TP53 P04637 5/20 1.00
ALDH1A1 P00352 5/20 1.00
HPGD P15428 5/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Kaempferol SCHEMBL1259228 1.00 MEN1 (1.00) MEN1KMT2ACYP1A2CYP3A4ABCB1
Kaempferol SCHEMBL18817 1.00 MEN1 (1.00) MEN1KMT2ACYP1A2CYP3A4ABCB1
Kaempferol SCHEMBL30655455 1.00 MEN1 (1.00) MEN1KMT2ACYP1A2CYP3A4ABCB1
Kaempferol SCHEMBL34461912 0.98 MEN1 (0.97) MEN1KMT2ACYP1A2CYP3A4ABCB1
Kaempferol SCHEMBL31256029 0.98 MEN1 (0.97) MEN1KMT2ACYP1A2CYP3A4ABCB1
Kaempferol SCHEMBL30544809 0.98 MEN1 (0.97) MEN1KMT2ACYP1A2CYP3A4ABCB1
Kaempferol SCHEMBL31749037 0.98 MEN1 (0.97) MEN1KMT2ACYP1A2CYP3A4ABCB1
Kaempferol SCHEMBL31577746 0.98 MEN1 (0.97) MEN1KMT2ACYP1A2CYP3A4ABCB1
Kaempferol SCHEMBL17237761 0.98 MEN1 (0.97) MEN1KMT2ACYP1A2CYP3A4ABCB1
Kaempferol SCHEMBL38651062 0.98 MEN1 (0.97) MEN1KMT2ACYP1A2CYP3A4ABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 476 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4724079-A2 METHODS AND COMPOSITIONS FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION Stealth BioTherapeutics Inc. (US) 2026-04-15 EP claimed
EP-4719404-A2 METHODS FOR ADDRESSING INJECTION SITE REACTIONS ASSOCIATED WITH THE ADMINISTRATION OF BEVEMIPRETIDE Stealth BioTherapeutics Inc. (US) 2026-04-08 EP claimed
EP-4642472-A1 PLANT HYDROETHANOLIC EXTRACTS O SIGMA CELL AND GENETIC LLC (US) 2025-11-05 EP claimed
EP-3871654-B1 OXIDATIVE HAIR COLOR REMOVER IN TABLET OR PELLET FORM BRIGHT INT LLC (US) 2025-11-05 EP claimed
EP-4622640-A1 COMPOSITIONS AND METHODS FOR MODULATING SLEEP AND USES THEREOF Brightseed, Inc. (US) 2025-10-01 EP claimed
EP-4533059-A1 ADDRESSING INJECTION SITE REACTIONS ASSOCIATED WITH THE ADMINISTRATION OF ELAMIPRETIDE Stealth BioTherapeutics Inc. (US) 2025-04-09 EP claimed
CN-119302342-A Composite antioxidant and preparation method thereof 西尼尔(山东)新材料科技有限公司 2025-01-14 CN claimed
US-20250009655-A1 BIPHASIC COMPOSITIONS COMPRISING ONE OR BOTH OF CARBONATE AND PHOSPHATE Natural Extraction Systems, LLC 2025-01-09 US claimed
WO-2024254164-A2 METHODS AND COMPOSITIONS FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION STEALTH BIOTHERAPEUTICS INC. (US) 2024-12-12 WO claimed
WO-2024243490-A2 METHODS FOR ADDRESSING INJECTION SITE REACTIONS ASSOCIATED WITH THE ADMINISTRATION OF BEVEMIPRETIDE STEALTH BIOTHERAPEUTICS INC. (US) 2024-11-28 WO claimed
WO-2023191839-A9 STABILIZED COMPOSITIONS OF RADIONUCLIDES AND USES THEREOF RAYZEBIO, INC. (US) 2023-11-09 WO claimed
WO-2023191839-A2 STABILIZED COMPOSITIONS OF RADIONUCLIDES AND USES THEREOF RAYZEBIO, INC. (US) 2023-10-05 WO claimed
US-11751593-B2 Sweetener and flavor compositions, methods of making and methods of use thereof EPC Natural Products Co., Ltd (CN) 2023-09-12 US claimed
US-20230139404-A1 Improved single-cell protein production using antioxidants THE PROTEIN BREWERY B.V. (NL) 2023-05-04 US claimed
WO-2022047147-A9 COMPOUNDS AND METHODS FOR PREVENTION AND TREATMENT OF VIRUS INFECTIONS Arjil Biotech Holding Company Limited (TW) 2023-02-09 WO claimed
WO-2022224217-A1 POLYPHENOLIC EXTRACT, METHODS AND USES THEREOF UNIVERSIDADE CATÓLICA PORTUGUESA - UCP (PT) 2022-10-27 WO claimed
WO-2022182527-A1 COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS Natural Extraction Systems, LLC (US) 2022-09-01 WO claimed
US-20220249434-A1 Reversal of Baldness in Men and Women through Cannabinoid Receptor Activation POSTREL RICHARD (US) 2022-08-11 US claimed
EP-4017585-A1 FLAVONOID DERIVATIVE FOR TREATING DENTAL CARIES Mühlbauer Technology GmbH (DE) 2022-06-29 EP claimed
US-20220184020-A1 Polyphenols as Modulators of Platelet Function THE BRIGHAM AND WOMEN'S HOSPITAL, INC. 2022-06-16 US claimed